IL13 and asthma: The systems evaluated included mature and developing mouse trachea, human airway epithelial cultures derived from human induced pluripotent stem cells, and primary human airway epithelial cultures subjected to asthma-like inflammatory conditions (interleukin-13 (IL-13) treated) or differentiated under mechanical stimulation (Organ-on-Chip models).